Clinicopathological variables
|
n†
|
TESTIN cases (%)
|
p-Value
|
---|
| |
Positive
|
Negative
| |
---|
Age (years)
| | | |
0.384
|
<56
|
68
|
12 (17.5)
|
49 (80.3)
| |
≥56
|
72
|
17 (23.6)
|
55 (76.4)
| |
Gender
| | | |
0.886
|
Female
|
45
|
9 (20.0)
|
36 (80.0)
| |
Male
|
95
|
20 (21.1)
|
75 (78.9)
| |
Tumor size (cm)
| | | |
0.789
|
<5
|
61
|
12 (19.7)
|
49 (80.3)
| |
≥5
|
79
|
17 (21.6)
|
62 (78.4)
| |
T stage
| | | |
0.441
|
T1
|
12
|
1 (8.3)
|
11 (91.7)
| |
T2
|
17
|
2 (11.8)
|
15 (88.2)
| |
T3
|
85
|
19 (22.4)
|
66 (77.6)
| |
T4
|
26
|
7 (26.9)
|
19 (73.1)
| |
N stage
| | | |
0.520
|
N0
|
44
|
6 (13.6)
|
38 (86.4)
| |
N1
|
42
|
9 (21.4)
|
33 (78.6)
| |
N2
|
43
|
11 (25.6)
|
32 (74.4)
| |
N3
|
11
|
3 (27.3)
|
8 (72.7)
| |
M stage
| | | |
0.997
|
M0
|
111
|
23 (20.7)
|
88 (79.3)
| |
M1
|
29
|
6 (20.7)
|
23 (79.3)
| |
Clinical stage
| | | |
0.686
|
I
|
17
|
2 (11.8)
|
15 (88.2)
| |
II
|
28
|
5 (17.9)
|
23 (82.1)
| |
III
|
51
|
11 (21.6)
|
40 (78.4)
| |
IV
|
44
|
11 (25.0)
|
33 (75.0)
| |
Differentiation
| | | |
0.007*
|
Well
|
3
|
2 (66.7)
|
1 (33.3)
| |
Moderate
|
30
|
12 (40.0)
|
18 (60.0)
| |
Poor
|
97
|
13 (13.4)
|
84 (86.6)
| |
Undifferentiated
|
10
|
2 (20.0)
|
8 (80.0)
| |
- † Number of cases in each group.
- * Statistically significant (p < 0.05).